CONVALIFE PHARMACEUTICALS CO.,LTD

About CONVALIFE PHARMACEUTICALS CO.,LTD

Convalife Pharmaceuticals is a commercial-stage biopharmaceutical company driven by efficient innovation, with a vision to develop breakthrough therapies. We focus on innovative medicines for cancer treatment, while also advancing drug R&D and commercialization targeting viral and aging-related diseases. Adopting a dual strategy balancing commercialization and clinical development, we have bui...

  • Country/Region:
    China
  • On CPHI since:
    2026
  • Employees:
    50 - 99
Company types
Biopharmaceutical company
Primary activities
Biopharmaceutical
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
Contact info

Products from CONVALIFE PHARMACEUTICALS CO.,LTD (1)

  • Hannaijia (Neratinib Maleate Tablets)

    Product Hannaijia (Neratinib Maleate Tablets)

    Hannaijia, the brand name of Neratinib Maleate Tablets, is an oral irreversible pan-human epidermal growth factor receptor (pan-HER) tyrosine kinase inhibitor. It is indicated for the extended adjuvant treatment of adult patients with early-stage HER2-positive breast cancer following adjuvant trastuzu...